Ventripoint Diagnostics Ltd (VPT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14 | 67 | 1,359 | 191 | 1,977 |
| Receivables | 68 | 80 | 100 | 129 | 64 |
| Inventories | 31 | 69 | 51 | 12 | 0 |
| TOTAL | $176 | $380 | $1,623 | $611 | $2,121 |
| Non-Current Assets | |||||
| PPE Net | 138 | 49 | 50 | 24 | 28 |
| Intangibles | 0 | 37 | 37 | 37 | 30 |
| TOTAL | $138 | $86 | $87 | $61 | $59 |
| Total Assets | $314 | $466 | $1,710 | $673 | $2,180 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 220 | N/A | N/A | 597 | 598 |
| Accounts payable and accrued liabilities | 1,196 | 729 | 678 | 842 | 813 |
| Accrued Expenses | 450 | 567 | 474 | 701 | 737 |
| Other current liabilities | 13 | 134 | 2,184 | 743 | 292 |
| TOTAL | $1,916 | $1,440 | $3,336 | $2,922 | $2,449 |
| Non-Current Liabilities | |||||
| Long Term Debt | 793 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 0 | 10 | 0 | 39 | 9 |
| TOTAL | $868 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,784 | $1,440 | $3,336 | $2,922 | $2,449 |
| Shareholders' Equity | |||||
| Common Shares | 29,480 | 28,624 | 26,565 | 22,881 | 28,862 |
| Retained earnings | -37,947 | -34,620 | -32,536 | -28,833 | -34,112 |
| TOTAL | $-2,469 | $-973 | $-1,626 | $-2,250 | $-270 |
| Total Liabilities And Equity | $314 | $466 | $1,710 | $673 | $2,180 |